Organ TransplantsPosted: 22nd May 2018 in Industry News
Organ donation and transplantation is a big discussion at the moment. Wales have trialled an opt-out system to help boost numbers on the organ donation list, and similar plans are being discussed for England and Scotland.
Myths around Hay FeverPosted: 04th May 2018 in Industry News
Hay fever is an inflammation in the nose which occurs when the immune system overreacts to allergens in the air. It does this as it mistakes pollen for something harmful like bacteria, which triggers the cold-like symptoms that comes with hay fever. Here's some myths that are still around surrounding the common condition...
ScandLas Meeting SuccessPosted: 03rd May 2018 in Company News
Agenda attended the annual ScandLAS meeting that held the title “Beyond legislation – Best practice in Animal Research” where the one of the main themes was how to achieve the highest possible scientific and welfare standards in animal research. The meeting was held in Kristiandsand in Southern Norway. The venue was on the coast, surrounded by Norwegian mountains and a number of lakes.
Audit success for AgendaPosted: 27th April 2018 in Company News
Agenda is pleased to announce that this week it has successfully passed its 6-monthly audit for ISO 9001, ISO27001 and ISO14001, this accreditation is fundamental to the quality management, information security and green processes that underpin our commitment to continually improving our service and adding value to our customers.
Manchester Facility AppointmentPosted: 23rd April 2018 in Company News
Agenda Life Sciences would like to welcome Steve Dean to Agenda who strengthens the Manchester based facility management team...
15 Wrong Health ‘Facts’Posted: 23rd April 2018 in Industry News
We are always told to ‘avoid that’ and ‘do this’, here’s 15 health ‘facts’ we’re often told which are in fact totally wrong...
ELRIG Research & Innovation 2018 – Day 2Posted: 19th April 2018 in Company News
Following a fabulously informative and inspiring day 1 which was focussed on oncology research, ELRIG’s Research and Innovation conference day 2 looked at neurosciences with speakers from GSK, Storm Therapeutics, Astex Pharmaceuticals, Sygnature Discovery and the universities of Cambridge and Oxford amonst some who shared their research and described new approaches.
ELRIG Research & Innovation 2018 – Day 1Posted: 17th April 2018 in Company News
Intended to capture current and emerging opportunities in drug discovery research, ELRIG’s Research & Innovation event spans 2 days and is packed with excellent presentations from key research groups focussing on new biology and new therapeutic targets for drug discovery. Held at the beautiful Homerton College in Cambridge, our local business development executive, Laura Gilbey, as been busy meeting research groups, key opinion leaders and suppliers. We wanted to blog some of the exciting content from todays presentations exploring drug research innovations and novel targets in one of the highest priority areas of medical need, namely oncology.